WASHINGTON, D.C. – Following the election of former Vice President Joe Biden, ACLA President Julie Khani issued the following statement: “ACLA and its members congratulate ... Read More
Washington, D.C. – Following today’s announcement by Centers for Medicare & Medicaid Services (CMS) on Medicare reimbursement rates for COVID-19 testing, ACLA President Julie Khani ... Read More
Washington, D.C. – Following the recent FDA decision to no longer review emergency use authorizations (EUAs) for lab-developed COVID-19 testing, ACLA President Julie Khani released ... Read More
Washington, D.C. – Following the recent announcement from the U.S. Department of Health and Human Services (HHS) that the U.S. Food and Drug Administration (FDA) ... Read More
WASHINGTON, D.C. – The National Consumers League, the American Clinical Laboratory Association (ACLA) and America’s Health Insurance Plans (AHIP) joined nearly 50 leading stakeholders representing ... Read More
WASHINGTON, D.C. – As ACLA member laboratories continue to navigate unprecedented demand and significant supply challenges, ACLA President Julie Khani issued the following statement: “In ... Read More
WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement: “ACLA member laboratories ... Read More
WASHINGTON, D.C. – Following additional guidance released today from the Department of Labor, the Department of Treasury, and the Department of Health and Human Services ... Read More
In a bipartisan letter to Secretary Azar, 30 lawmakers urge HHS to designate funds to help clinical laboratories expand capacity WASHINGTON, D.C. – As clinical ... Read More
WASHINGTON, D.C. – As ACLA reviews the new data reporting guidance released today by the Department of Health and Human Services (HHS), ACLA President Julie Khani ... Read More
